Relation of angiotensin-converting enzyme inhibitor treatment to insulin-like growth factor-1 serum levels in subjects >65 years of age (the InCHIANTI study).
about
The renin-angiotensin system and prevention of age-related functional decline: where are we now?Optimizing the benefits of exercise on physical function in older adults.Increase in insulin-like growth factor 1 (IGF-1) and insulin-like growth factor binding protein 1 after supplementation with selenium and coenzyme Q10. A prospective randomized double-blind placebo-controlled trial among elderly Swedish citizens.Optimal management of sarcopenia.Effects of ACE-inhibition on IGF-1 and IGFBP-3 concentrations in older adults with high cardiovascular risk profile.Effect of Angiotensin-Converting Enzyme Inhibitors on Physical Function in Elderly Subjects: A Systematic Review and Meta-Analysis.Novel intriguing strategies attenuating to sarcopeniaModulation of GH/IGF-1 axis: potential strategies to counteract sarcopenia in older adults.Angiotensin-converting enzyme inhibitor use and incident frailty in women aged 65 and older: prospective findings from the Women's Health Initiative Observational StudyRelationship between use of proton pump inhibitors and IGF system in older subjects.IGF-1 and atherothrombosis: relevance to pathophysiology and therapy.Respiratory diseases and muscle dysfunction.Is there a new role for angiotensin-converting-enzyme inhibitors in elderly patients?Effects of enalapril or nifedipine on muscle strength or functional capacity in elderly subjects. A double blind trial.Recent advances in pharmacological, hormonal, and nutritional intervention for sarcopenia.
P2860
Q28085528-3AEE2393-9DA6-4DC1-8FDC-26DA9B571289Q33779905-EAF62FB9-87B7-468C-9062-419A2229FEC1Q33793116-049DC732-CCBF-4C01-8826-97956730EDDAQ34121822-FE150BEE-EDFD-4B76-9998-E3A0E57AF622Q35031632-0CE1AD00-B9BF-4878-B7AB-A8EA9B4A0374Q35749354-FDFEBFDC-829D-4700-B718-37B1AAE50A7CQ35829811-E57269A6-5F38-4641-937B-B3F94CB490A3Q37257924-CC10C095-0A4C-4F22-96DA-36F704587569Q37350734-4E0C526E-D346-4513-8E28-912105D9D7BAQ37361889-9FB0EAB2-23FD-4F0F-9C3F-9C0849033133Q37829755-47AC7007-4457-4178-B17A-8FAD6DA0A80AQ37979250-84B2272F-DC0A-42A0-A333-41B82F62842DQ41495992-51BCF47F-8C29-4EF7-A95A-855EDFE67D9BQ45979864-199B8E0D-9501-4B11-8251-48A4410A6E66Q47636085-A858BE83-4CEB-425D-A023-D75D4D688064
P2860
Relation of angiotensin-converting enzyme inhibitor treatment to insulin-like growth factor-1 serum levels in subjects >65 years of age (the InCHIANTI study).
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 31 March 2006
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Relation of angiotensin-conver ...... of age (the InCHIANTI study).
@en
Relation of angiotensin-conver ...... s in subjects >65 years of age
@nl
type
label
Relation of angiotensin-conver ...... of age (the InCHIANTI study).
@en
Relation of angiotensin-conver ...... s in subjects >65 years of age
@nl
prefLabel
Relation of angiotensin-conver ...... of age (the InCHIANTI study).
@en
Relation of angiotensin-conver ...... s in subjects >65 years of age
@nl
P2093
P2860
P50
P1476
Relation of angiotensin-conver ...... s of age (the InCHIANTI study)
@en
P2093
Giorgio Valenti
Luigi Ferrucci
Marcello Maggio
Marco Pahor
Samer S Najjar
Shari M Ling
Shehzad Basaria
Stefania Bandinelli
P2860
P304
P356
10.1016/J.AMJCARD.2005.11.089
P407
P577
2006-03-31T00:00:00Z